Coherus BioSciences Announces New Employment Inducement Grants
August 22 2023 - 5:35PM
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq:
CHRS), today announced that effective August 20, 2023, the
compensation committee of the Company’s board of directors granted
options to purchase an aggregate of 77,000 shares of the common
stock of the Company to newly hired employees with a per share
exercise price of $4.47, the closing trading price on August 18,
2023, the last trading date preceding the grant date. One Vice
President level executive was granted options to purchase 45,000
shares; and four additional non-officer employees were granted
options to purchase an aggregate of 32,000 shares.
The stock options were granted pursuant to the Coherus
BioSciences, Inc. 2016 Employment Commencement Incentive Plan,
which was approved by the Company’s board of directors in June 2016
under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity
grants to induce new employees to enter into employment with the
Company.
Coherus BioSciences Contact Information:
IR ContactMarek CiszewskiCoherus BioSciences,
Inc.IR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jul 2023 to Jul 2024